Effect of transdermally administered hyoscine methobromide on nocturnal acid secretion in patients with duodenal ulcer.
Use of anticholinergic drugs in treatment of duodenal ulcers is limited by the side effects of widespread parasympathetic blockade evoked by usual therapeutic doses. A study was conducted into the effectiveness of transdermal delivery of hyoscine methobromide using a new system which releases the drug into the circulation at a controlled rate. In six patients whose duodenal ulcer had healed secretion of acid was measured over two nights, the first on placebo and the second on hyoscine methobromide. All patients responded to the active drug and showed a significant inhibition of acid secretion. Four subjects complained of a dry mouth after overnight treatment with hyoscine methobromide; no other side effects were reported. Transdermal delivery of anticholinergic drugs may be useful in maintenance treatment of duodenal ulcers and further clinical tests are indicated.
D000328:Adult; D004381:Duodenal Ulcer / Q000188:drug therapy*; D004423:Ear; D005744:Gastric Acid / Q000378:metabolism*; D005745:Gastric Acidity Determination; D006801:Humans; D007263:Infusions, Parenteral; D008297:Male; D019832:N-Methylscopolamine; D010276:Parasympatholytics / Q000008:administration & dosage* / Q000494:pharmacology; D012602:Scopolamine Derivatives / Q000008:administration & dosage*; D013997:Time Factors
D010276:Parasympatholytics; D012602:Scopolamine Derivatives; D019832:N-Methylscopolamine